Ijaz Ahmed Khan

Ijaz Ahmed Khan

Auto-generated profile, based on publicly available information

Ijaz Ahmed Khan

Department of Chemistry Quaid‐i‐Azam University 45320 Islamabad Pakistan

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2019 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
IKIjaz A. Khan
Ijaz A. Khan
Hidayat HussainHidayat Hussain
Hidayat Hussain
TYTariq Yasin
Tariq Yasin
MIMuhammad Inaam‐Ul‐Hassan
Muhammad Inaam‐Ul‐Hassan

5 July 2017 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
IKIjaz Ahmed Khan
Ijaz Ahmed Khan
TYTariq Yasin
Tariq Yasin
Hidayat HussainHidayat Hussain
Hidayat Hussain

25 November 2018 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
MHMuhammad Inaam Ul Hassan
Muhammad Inaam Ul Hassan
STShaista Taimur
Shaista Taimur
IKIjaz Ahmed Khan
Ijaz Ahmed Khan
TYTariq Yasin
Tariq Yasin
SASyed Wasim Ali
Syed Wasim Ali

11 December 2006 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
ETEric M. Thorn
Eric M. Thorn
IKIjaz A. Khan
Ijaz A. Khan

1 January 2008 in American Journal of Therapeutics
Verified
Journal Article
Closed access
DLDhanunjaya Lakkireddy
Dhanunjaya Lakkireddy
Wilbert AronowWilbert Aronow
Wilbert Aronow
TBTimothy Bateman
Timothy Bateman
IMIan MBBS McGhee
Ian MBBS McGhee
CNChandra Nair
Chandra Nair
IKIjaz A Khan
Ijaz A Khan
We retrospectively evaluated perfusion defect presence, extent, and severity in 158 consecutive patients receiving beta blockers, who underwent adenosine single-photon-emission computed tomography (SPECT) myocardial perfusion imaging (MPI) and coronary angiography. Seventy-six patients (group 1) had their beta blockers withdrawn 48 hours prior to testing, and 82 patients (group 2) remained on the beta blocker regimen. Groups 1 and 2 were similar in gender, age, pretest symptoms, and history of coronary artery disease (CAD). Group 1 patients had higher resting heart rates (79 ± 19/min versus 68 ± 13/min; P < 0.001), peak heart rates (91 ± 21/min versus 80 ± 15/min; P < 0.001), resting diastolic blood pressures (82 ± 14 mm Hg versus 74 ± 13 mm Hg; P < 0.001), peak systolic blood pressures (139 ± 23 mm Hg versus 124 ± 23 mm Hg; P < 0.001), and peak diastolic blood pressures (72 ± 12 mm Hg versus 68 ± 11 mm Hg; P = 0.04) than group 2 patients. Group 1 also had a higher incidence of angina during the 48 hours off beta blockers than group 2 (10% versus 2%; P < 0.001). There was no significant difference between the two groups in symptoms and side effects during adenosine infusion, quantitated lung/heart ratio, visually assessed lung uptake, transient ischemic dilation, post-stress ejection fraction, summed stress score, summed rest score, and summed difference score. In conclusion, in patients with CAD, beta blocker therapy does not affect the extent, severity, and reversibility of perfusion defects on adenosine SPECT MPI.

1 July 1998 in Cardiology
Verified
Journal Article
Closed access
PDF file
SRSyed I. Rahmatullah
Syed I. Rahmatullah
IKIjaz A. Khan
Ijaz A. Khan
VNVinod M. Nair
Vinod M. Nair
TKTarif Kannan
Tarif Kannan
BVBalendu C. Vasavada
Balendu C. Vasavada
TSTerrence J. Sacchi
Terrence J. Sacchi
The origination of all three major coronary arteries from three separate ostia in the right sinus of Valsalva is an exceedingly rare coronary anomaly. Few radiographic and clinical details of this anomaly are available in the literature. We describe this anomaly in a patient with acute myocardial infarction who remained asymptomatic until the 8th decade of her life. Atherosclerotic narrowing of the normally originating right coronary artery caused the acute myocardial infarction. Anomalous left anterior descending and left circumflex arteries were free of any significant obstruction.